Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Salvador Augustin"'
Autor:
Jesús Rivera-Esteban, Alba Jiménez-Masip, Sergio Muñoz-Martínez, Salvador Augustin, Rafael A. Guerrero, Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodríguez-Frías, Elisabet Turu, Andrés Marco, Juan M. Pericàs, on behalf of the PRISONAFLD Study Group Collaborators
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 23, p 7276 (2023)
Background and Aims: The prevalence of chronic non-communicable diseases, particularly metabolic syndrome (MetS), has increased among the prison population. Nevertheless, we have limited data on metabolic dysfunction-associated steatotic liver diseas
Externí odkaz:
https://doaj.org/article/a7afb9cf15e54ce894f5c8be1eec74a8
Autor:
Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín, José Manuel Carrascosa
Publikováno v:
Life, Vol 13, Iss 2, p 419 (2023)
Interleukin 17 (IL-17) is an effector cytokine that plays a key role in the pathogenesis of both psoriasis and metabolic-associated fatty liver disease (MAFLD), a condition that is more prevalent and severe in patients with psoriasis. In liver inflam
Externí odkaz:
https://doaj.org/article/0fd053049b0f4bc583085e6c55dbf3f0
Autor:
Iris Pinheiro, Aurora Barberá, Imma Raurell, Federico Estrella, Marcel de Leeuw, Selin Bolca, Davide Gottardi, Nigel Horscroft, Sam Possemiers, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1191 (2022)
The gut microbiome has a recognized role in Non-alcoholic fatty liver disease (NAFLD) and associated comorbidities such as Type-2 diabetes and obesity. Stool transplantation has been shown to improve disease by restoring endothelial function and insu
Externí odkaz:
https://doaj.org/article/b816e97e8e144595a5b84ac1bf9d6738
Autor:
Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan M. Pericàs, David Martinez Selva
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1015 (2022)
Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis in western countries. Insulin resistance (IR), type 2 diabetes (T2D), and the polymorphisms patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 and transmembrane 6 super
Externí odkaz:
https://doaj.org/article/be7ffce3ddb348809c095e89e3b3fb5a
Autor:
Mònica Pons, Jesús Rivera-Esteban, Ramiro Manzano, Juan Bañares, María Bermúdez, Víctor Vargas, Maria Teresa Salcedo-Allende, Lluís Castells, Salvador Augustin, Beatriz Mínguez, Juan M. Pericàs
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 9, p 2466 (2022)
Background: The potential role of non-invasive tests (NITs) for liver fibrosis for hepatocellular carcinoma (HCC) prediction remains poorly known. Methods: Retrospective analysis of a NAFLD cohort from a single university hospital in Barcelona, Spain
Externí odkaz:
https://doaj.org/article/d042f63718c84f9082dbefea3fe46a8f
Autor:
Albert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, Yolanda Villena, Rosa Lopez-Martínez, Salvador Augustín, Mònica Pons, Luz-Maria Cruz, Ariadna Rando-Segura, Belen Enfedaque, Mar Riveiro, Ernesto Casis, Roser Ferrer-Costa, Maria Buti, Francisco Rodriguez-Frias
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2236 (2021)
Liver disease is frequently asymptomatic, challenging early identification in the primary care setting. The fibrosis 4 (FIB4) index is a liver fibrosis biomarker that is a potential alternative to liver biopsy for diagnosing and managing liver diseas
Externí odkaz:
https://doaj.org/article/2a898270fbd34cc1b5bd764a960475d9